Steven Treon - 25 Years at Dana-Farber!
I first met Dr. Steven Treon in February, 2004 when I joined the Bing Center as a volunteer. As a fellow BU alumnus, and 30 year high tech engineer, I was immediately impressed with Steve's ability to explain complex subject matter (i.e. blood cancer research) in ways that a "lay-person" can understand. I consider it a privilege to have attended his lab meetings where the latest research was regularly presented and discussed. It felt like I was auditing a post-graduate level biology class (and I never did well in chemistry or biology). Steve is always pushing the envelope, whether it is working with the pharmaceutical companies to develop custom molecules to aid with specific research projects, or to develop targeted therapies to be used in clinical trials, and eventually made generally available to patients. No matter what activity was taking place, Steve was involved in every step of the process.
Over the years, I have seen the Bing Center serve as a "training ground" for young researchers advancing in their careers. Due, in large part, to Steve's mentorship, many have gone onto MDs, Ph.Ds and even "MD, Ph.D". Others have gone into other areas of research. Steve always stressed the importance of being a "scientist", being curious, and striving for excellence, and that shows in his incredible body of work. Steve's efforts over the past 25 years have made the Bing Center a world class research and treatment center for Waldenstrom's Macroglobulinemia. Thousands of WM patients from all over the world have come to the Bing Center for consultation and/or treatment. The research conducted there has spearheaded the development of new therapies which have extended the lifespans and quality of life for WM patients by decades.
Waldenstrom's Macroglobulinemia Clinic
The Waldenstrom's Macroglobulinemia Clinic at the DFCI is devoted to the care of patients with Waldenstrom's Macroglobulinemia and related IgM disorders, including IgM MGUS, Myeloma and Neuropathies.
For more information on the WM Clinic at DFCI, please visit the DFCI Center for Hematologic-Oncology/Waldenstrom's Macroglobulinemia Clinic.
Basic Research
Waldenström’s macroglobulinemia (WM) is a distinct B-cell malignancythat results from the accumulation, predominantly in the bone marrow, of clonally related B type lymphocytes, lymphoplasmacytic cells and plasma cells which secrete a monoclonal IgM protein.1 This condition is considered to correspond to the lymphoplasmacytic lymphoma (LPL) as defined by the World Health Organization classification system.2 Most cases of LPL are WM, with less than 5% of cases made up of IgA, IgG and non-secreting LPL ...
Latest Bing Center News
Waldenstrom Macroglobulinemia: Who Gets What and When?
As many as 50% of people at the time of their Waldenstrom macroglobulinemia (WM) diagnosis won’t need drug therapy for a number of years. We spoke with Shayna Sarosiek, MD, hematologist/oncologist from at the Bing Center for Waldenström’s Macroglobulinemia at Dana-Farber Cancer Institute in Boston, to share what “supportive treatments” could help in the meantime.
We want YOU to join our Jimmy FundRaiser community!
We want YOU to join our Jimmy FundRaiser community! The Dana-Farber Community Fundraising Event (CFE) program is where community members hold their own fundraisers or events on behalf of Dana-Farber and the Jimmy Fund. Fundraisers range from bake sales to hiking mountains, walking a 5k, and holding a virtual cooking class. Holding a fundraiser can be an outlet for individuals or families who want to take an “action” towards supporting a loved one, remembering a loved one, or fighting their own fight against cancer.
Zachary Hunter - 20 Years at Dana-Farber!
I first met Zach in 2004 when I joined the Bing Center as a volunteer. He was managing clinical trials, and immediately became my "go-to" person when I needed help or advice on any technical issue. Zach created the first WM Workshop website, and then taught me how to maintain it. I was able to build on that knowledge to create other websites.
What insights can multi-omics provide into the mechanism of disease progression in WM?
On behalf of the International Waldenstrom's Macroglobulinemia Foundation (IWMF), the Lymphoma Hub was pleased to speak with Zachary Hunter, Dana-Farber Cancer Institute, Boston, US. We asked, What insights can multi-omics provide into the mechanism of disease progression in Waldenstrom’s macroglobulinemia (WM)?
My Waldenström Macroglobulinemia, Miracle Number Three
Dear Fellow Cancer Patient: As I believe in universal love for ALL, I’m reaching out to you, whether we have met or not, to invite you to join me in embracing the concept of medical miracles no matter what kind of cancer you have.
Update on Bing Neel Syndrome - Shayna Sarosiek April, 2023
From Bing-Neel Co-Leader & Lifeline Volunteer, Julie Davidson: "The Bing-Neel Support Group just had our Spring meeting. We featured a wonderfully informative video by Dr. Shayna Sarosiek, senior physician at the Dana-Farber Cancer Institute’s Bing Center for Waldenstrom’s Macroglobulinemia.
2022 March Dr. Treon "Rounds" with Canadian Medical Professionals
We invited Canadian medical professionals to listen to Dr. Treon of the DFCI. (There were 2 sessions - EST & PST) He provided a very thorough update on the state of WM and its treatment.
IWWM-11 (Madrid 2022) Consensus Panel Reports
Consensus panel reports from the 11th International Workshop on Waldenstrom's Macroglobulinemia.
Dana-Farber Researchers Use Machine Learning to Understand Rare Familial Blood Cancer
Researchers at Dana-Farber have put together a data atlas that includes a range of genomic, transcriptomic, epigenetic, and clinical data from patients and healthy donors to try to understand familial WM.
Topics from the 11th IWWM Workshop in Madrid
Bing Center WM experts discuss various topics from the 11th IWWM in Madrid.